PSA PROGRESSION
Clinical trials for PSA PROGRESSION explained in plain language.
Never miss a new study
Get alerted when new PSA PROGRESSION trials appear
Sign up with your email to follow new studies for PSA PROGRESSION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Targeted radiation after prostate surgery shows promise in cancer control
Disease control OngoingThis study looks at whether a special type of radiation called stereotactic body radiotherapy (SBRT) can help prevent prostate cancer from coming back after surgery. About 92 men who had their prostate removed and have signs of remaining cancer will receive SBRT. The goal is to s…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 22, 2026 12:05 UTC
-
Could a common mushroom help fight prostate cancer?
Disease control TerminatedThis phase 2 trial tests whether white button mushroom extract can lower PSA levels in men with prostate cancer that has returned after treatment or is low-risk and not yet treated. About 133 men will take the supplement or be observed. The goal is to see if the mushroom affects …
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 22, 2026 11:55 UTC
-
New hope for hard-to-treat prostate cancer: adding immunotherapy to current drug
Disease control OngoingThis study tests whether adding the immunotherapy drug pembrolizumab can help men whose advanced prostate cancer has stopped responding to the standard drug enzalutamide. About 58 men with castration-resistant prostate cancer that has spread will receive pembrolizumab while conti…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: OHSU Knight Cancer Institute • Aim: Disease control
Last updated Jun 11, 2026 12:12 UTC
-
New hope for tough prostate cancer: drug cocktails under trial
Disease control OngoingThis study tests different combinations of approved drugs in 196 men with advanced prostate cancer that has spread and no longer responds to hormone therapy. The goal is to see which combinations work best to extend life and control the cancer. Participants receive standard hormo…
Matched conditions: PSA PROGRESSION
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 08, 2026 13:10 UTC